Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000792920 | SCV000932249 | uncertain significance | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 867 of the MSH3 protein (p.Ile867Thr). This variant is present in population databases (rs187411724, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MSH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 639989). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV001016072 | SCV001176984 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-04-21 | criteria provided, single submitter | clinical testing | The p.I867T variant (also known as c.2600T>C), located in coding exon 19 of the MSH3 gene, results from a T to C substitution at nucleotide position 2600. The isoleucine at codon 867 is replaced by threonine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Sema4, |
RCV001016072 | SCV002536069 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-11-29 | criteria provided, single submitter | curation | |
Baylor Genetics | RCV003461072 | SCV004197001 | uncertain significance | Endometrial carcinoma | 2024-03-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005036131 | SCV005666208 | uncertain significance | Endometrial carcinoma; Familial adenomatous polyposis 4 | 2024-06-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000792920 | SCV005848322 | uncertain significance | not provided | 2024-08-12 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |